We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Stem Cell Patch Repairs Damaged Hearts

By HospiMedica International staff writers
Posted on 06 Nov 2009
A newly identified human cardiac master stem cell is being used to artificially create a strip of ventricular heart muscle tissue that essentially works "like slapping a Band-Aid on the heart.”

Researchers at the Harvard Stem Cell Institute (HSCI, Boston, MA, USA) employed a two-colored fluorescent reporter system to isolate first and second heart field (FHF and SHF, respectively) progenitor cells from developing mouse embryos and embryonic stem cells; genome-wide profiling of coding and noncoding transcripts revealed the distinct molecular signatures of these progenitor populations. More...
The researchers then identified a committed ventricular progenitor cell in lineage that was capable of limited in vitro expansion, differentiation, and assembly into functional ventricular muscle tissue, representing a combination of tissue engineering and stem cell biology. The committed ventricular progenitor cell was then grown into a patch of tissue on a thin layer of polymer film, using technology first developed for the manufacture of microelectronic components; once placed on the film, the cells reorganized themselves spontaneously to form a section of cardiac tissue. The created heart muscle tissue was implanted into mice where the ventricular muscle had died, and the dimensions of the piece of were controlled by limiting their growth into the heart. The researchers added that other questions would have to be answered before the stem cell technology could be put to medical use, such as how to create an appropriate blood supply for the grafted heart muscle tissue. The study was published online on October 15, 2009 in Science.

"What we would like to do now is find new ways to deliver a heart patch that is three-dimensional; for doing this in animals, I anticipate being able to do some version of this in the coming year,” said lead author Kenneth Chien, M.D., Ph.D., director of the Massachusetts General Center for Cardiovascular Research (CVRC, Boston, USA) and a member of the HSCI. "Talking clinically, I believe that in five years or so the groundwork would be laid for very early clinical studies to deliver these cells to humans.”

One possibility of the new technology is that the ventricular patch would be placed over the area of tissue damaged by a heart attack (much like a plaster), where it would expand and grow into working heart muscle. Another is that the cells would be injected into the damaged area, with the hope that they would grow to form healthy new tissue.

Related Links:

Harvard Stem Cell Institute
Massachusetts General Center for Cardiovascular Research



Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Absorbable Monofilament Mesh
Phasix Mesh
Radiation Safety Barrier
RayShield Intensi-Barrier
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.